Literature DB >> 24650964

Analysis of risk factors for pancreatic duct stones formation in patients with alcoholic chronic pancreatitis.

Guo-wei Zhang1, Jian-hua Lin2, Jian-ping Qian3, Jie Zhou4.   

Abstract

BACKGROUND: Alcoholic chronic pancreatitis (ACP) is the dominant cause of chronic pancreatitis (CP). As a main complication of CP, the formation of pancreatic duct stones (PDS) compromises pancreatic function and symptomatic patients are often subjected to aggressive treatments. The present study aimed to identify PDS risk factors in patients with ACP.
METHODS: A retrospective analysis of 93 ACP patients was performed; patients were divided into two groups: ACP with PDS (n = 48) and ACP without PDS (n = 45). Fourteen potential factors were analyzed by univariate and multivariate analyses to identify independent risk factors of PDS formation in ACP patients. A comparison of demographic and clinical characteristics between ACP patients with PDS and non-ACP patients with PDS (n = 43) was also carried out.
RESULTS: ACP accounted for 47.7% (93/195) of CP in this cohort. Among ACP patients, the morbidity of PDS was 51.6% (48/93). Significant risk factors of PDS formation for ACP patients included duration of drinking ≥24.7 years (OR, 9.036; 95% CI, 2.737-29.837; p < 0.001); daily alcohol consumption ≥147.0 g (OR, 3.147; 95% CI, 1.040-9.522; p = 0.042); and MPD narrowing (OR, 7.245; 95% CI, 2.205-23.811; p = 0.001). Shorter periods between diagnosis and PDS formation (PDP) were observed in ACP patients than non-ACP patients.
CONCLUSIONS: Alcohol consumption accelerates the progression of PDS formation in patients with CP.
Copyright © 2014 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcohol; Chronic pancreatitis; Pancreatic duct stones; Risk factors

Mesh:

Year:  2014        PMID: 24650964     DOI: 10.1016/j.pan.2014.01.002

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  3 in total

Review 1.  Toxic-metabolic Risk Factors in Pediatric Pancreatitis: Recommendations for Diagnosis, Management, and Future Research.

Authors:  Sohail Z Husain; Veronique Morinville; John Pohl; Maisam Abu-El-Haija; Melena D Bellin; Steve Freedman; Peter Hegyi; Melvin B Heyman; Ryan Himes; Chee Y Ooi; Sarah J Schwarzenberg; Danielle Usatin; Aliye Uc
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-04       Impact factor: 2.839

2.  Medical Management of Chronic Pancreatitis in Children: A Position Paper by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Pancreas Committee.

Authors:  A Jay Freeman; Asim Maqbool; Melena D Bellin; Kenneth R Goldschneider; Amit S Grover; Cheryl Hartzell; Travis L Piester; Flora Szabo; Bridget Dowd Kiernan; Racha Khalaf; Rakesh Kumar; Mirta Rios; Sohail Z Husain; Veronique D Morinville; Maisam Abu-El-Haija
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-02-01       Impact factor: 3.288

3.  HDAC inhibitors promote pancreatic stellate cell apoptosis and relieve pancreatic fibrosis by upregulating miR-15/16 in chronic pancreatitis.

Authors:  Ting Ji; Weiguang Feng; Xiangcheng Zhang; Kui Zang; Xingxing Zhu; Futai Shang
Journal:  Hum Cell       Date:  2020-06-11       Impact factor: 4.174

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.